Annual D&A
$17.55 M
-$958.00 K-5.18%
December 31, 2024
Summary
- As of March 6, 2025, IBRX annual depreciation & amortization is $17.55 million, with the most recent change of -$958.00 thousand (-5.18%) on December 31, 2024.
- During the last 3 years, IBRX annual D&A has risen by +$3.32 million (+23.29%).
- IBRX annual D&A is now -5.18% below its all-time high of $18.51 million, reached on December 31, 2023.
Performance
IBRX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$4.15 M
-$285.00 K-6.42%
December 31, 2024
Summary
- As of March 6, 2025, IBRX quarterly depreciation & amortization is $4.15 million, with the most recent change of -$285.00 thousand (-6.42%) on December 31, 2024.
- Over the past year, IBRX quarterly D&A has dropped by -$285.00 thousand (-6.42%).
- IBRX quarterly D&A is now -20.51% below its all-time high of $5.23 million, reached on December 31, 2022.
Performance
IBRX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$17.55 M
-$458.00 K-2.54%
December 31, 2024
Summary
- As of March 6, 2025, IBRX TTM depreciation & amortization is $17.55 million, with the most recent change of -$458.00 thousand (-2.54%) on December 31, 2024.
- Over the past year, IBRX TTM D&A has dropped by -$458.00 thousand (-2.54%).
- IBRX TTM D&A is now -8.22% below its all-time high of $19.13 million, reached on September 30, 2023.
Performance
IBRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
IBRX Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -5.2% | -6.4% | -2.5% |
3 y3 years | +23.3% | -6.4% | -2.5% |
5 y5 years | +25.0% | -6.4% | -2.5% |
IBRX Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -5.2% | +23.3% | -20.5% | +15.6% | -8.2% | +23.3% |
5 y | 5-year | -5.2% | +37.8% | -20.5% | +86.6% | -8.2% | +407.2% |
alltime | all time | -5.2% | +37.8% | -20.5% | +86.6% | -8.2% | +407.2% |
ImmunityBio Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $17.55 M(-5.2%) | $4.15 M(-6.4%) | $17.55 M(-2.5%) |
Sep 2024 | - | $4.44 M(+0.7%) | $18.01 M(-0.5%) |
Jun 2024 | - | $4.41 M(-3.3%) | $18.11 M(-1.5%) |
Mar 2024 | - | $4.55 M(-1.2%) | $18.39 M(-0.7%) |
Dec 2023 | $18.51 M(+1.4%) | $4.61 M(+1.7%) | $18.51 M(-3.2%) |
Sep 2023 | - | $4.54 M(-3.1%) | $19.13 M(+0.2%) |
Jun 2023 | - | $4.68 M(+0.0%) | $19.09 M(+1.3%) |
Mar 2023 | - | $4.68 M(-10.4%) | $18.85 M(+3.2%) |
Dec 2022 | $18.26 M | $5.23 M(+16.1%) | $18.26 M(+9.8%) |
Sep 2022 | - | $4.50 M(+1.3%) | $16.63 M(+5.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2022 | - | $4.44 M(+8.7%) | $15.82 M(+3.0%) |
Mar 2022 | - | $4.09 M(+13.8%) | $15.36 M(+7.9%) |
Dec 2021 | $14.24 M(+11.8%) | $3.60 M(-2.5%) | $14.24 M(+10.6%) |
Sep 2021 | - | $3.69 M(-7.5%) | $12.87 M(+1.0%) |
Jun 2021 | - | $3.98 M(+34.1%) | $12.74 M(+4.0%) |
Mar 2021 | - | $2.97 M(+33.5%) | $12.25 M(-3.8%) |
Dec 2020 | $12.74 M(-9.3%) | $2.23 M(-37.4%) | $12.74 M(+21.2%) |
Sep 2020 | - | $3.55 M(+1.6%) | $10.51 M(+51.1%) |
Jun 2020 | - | $3.50 M(+1.1%) | $6.96 M(+101.1%) |
Mar 2020 | - | $3.46 M | $3.46 M |
Dec 2019 | $14.04 M | - | - |
FAQ
- What is ImmunityBio annual depreciation & amortization?
- What is the all time high annual D&A for ImmunityBio?
- What is ImmunityBio annual D&A year-on-year change?
- What is ImmunityBio quarterly depreciation & amortization?
- What is the all time high quarterly D&A for ImmunityBio?
- What is ImmunityBio quarterly D&A year-on-year change?
- What is ImmunityBio TTM depreciation & amortization?
- What is the all time high TTM D&A for ImmunityBio?
- What is ImmunityBio TTM D&A year-on-year change?
What is ImmunityBio annual depreciation & amortization?
The current annual D&A of IBRX is $17.55 M
What is the all time high annual D&A for ImmunityBio?
ImmunityBio all-time high annual depreciation & amortization is $18.51 M
What is ImmunityBio annual D&A year-on-year change?
Over the past year, IBRX annual depreciation & amortization has changed by -$958.00 K (-5.18%)
What is ImmunityBio quarterly depreciation & amortization?
The current quarterly D&A of IBRX is $4.15 M
What is the all time high quarterly D&A for ImmunityBio?
ImmunityBio all-time high quarterly depreciation & amortization is $5.23 M
What is ImmunityBio quarterly D&A year-on-year change?
Over the past year, IBRX quarterly depreciation & amortization has changed by -$285.00 K (-6.42%)
What is ImmunityBio TTM depreciation & amortization?
The current TTM D&A of IBRX is $17.55 M
What is the all time high TTM D&A for ImmunityBio?
ImmunityBio all-time high TTM depreciation & amortization is $19.13 M
What is ImmunityBio TTM D&A year-on-year change?
Over the past year, IBRX TTM depreciation & amortization has changed by -$458.00 K (-2.54%)